Webinar | March 23, 2021

Host Cell Protein Analysis By ELISA And Orthogonal Methods In Vaccine And Gene Therapy Development

Next generation recombinant vaccines and gene therapy products require clinical and commercial manufacturing of protein antigens and/or viral vectors produced using cell culture technologies. In this webinar, we discuss orthogonal Antibody Affinity Extraction (AAE™) and Mass Spectrometry (MS) methods used to assess ELISA Ab coverage to HCPs present in a process and identify process-specific HCP that may co-purify with a drug substance. Case studies of HEK 293, Sf9 and Vero cell-based processes are presented.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: